Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)

Phase Distribution

Ph not_applicable
5
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials
Showing 5 of 5
completednot_applicable

THC Crossover Study

NCT04429568
completednot_applicable

Clinical Pharmacology of Electronic Cigarettes

NCT02470754
completednot_applicable

Comparison of Electronic Cigarettes and Tobacco Cigarettes on Cardiovascular Function and Oxidative Stress

NCT03036644
completednot_applicable

Vascular EffectS of regUlar Cigarettes Versus electronIc Cigarette USe

NCT02878421
completednot_applicable

Neurophysiological and Immunological Effects of the Transition From Combustible to Electronic Cigarettes

NCT02433015

Clinical Trials (5)

Showing 5 of 5 trials
NCT04429568Not Applicable

THC Crossover Study

Completed
NCT02470754Not Applicable

Clinical Pharmacology of Electronic Cigarettes

Completed
NCT03036644Not Applicable

Comparison of Electronic Cigarettes and Tobacco Cigarettes on Cardiovascular Function and Oxidative Stress

Completed
NCT02878421Not Applicable

Vascular EffectS of regUlar Cigarettes Versus electronIc Cigarette USe

Completed
NCT02433015Not Applicable

Neurophysiological and Immunological Effects of the Transition From Combustible to Electronic Cigarettes

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5